ENTA
#3085
Enanta Pharmaceuticals, Inc. - Common Stock
13.3 6 USD
0.00%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+0.23%
Changement Mensuel
+5.20%
Evolution sur 6 mois
-4.71%
Changement Annuel
+53.56%
Clôture Précédente
13.3 3
Open
13.3 8
Low
13.3 1
High
13.4 6
Volume
24
Financials
- Market Capitalization 389.12 M
- Employee 120
- Founded 1995
- CEO N/A
- Website www.enanta.com
- Headquarter Massachusetts, United States
- FIGI BBG001V9NSB4
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-6.02
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3048 |  XFOR X4 Pharmaceuticals, Inc. - Common Stock | 4.09 USD | +1.24% | -1.45% | +2.00% | +37.71% | 405.51 M USD | ||
| 3051 |  LRMR Larimar Therapeutics, Inc. - Common Stock | 3.89 USD | +1.83% | -6.27% | +1.57% | +6.28% | 404.10 M USD | ||
| 3096 |  EYPT EyePoint, Inc. - Common Stock | 4.47 USD | -0.67% | -13.54% | -63.78% | -62.75% | 385.37 M USD | ||
| 3101 |  CTNM Contineum Therapeutics, Inc. - Common stock | 16.64 USD | +2.46% | -1.83% | +9.33% | +8.97% | 384.37 M USD |